Search Results
Results found for "Jovanni D Ahmad"
- Glyco-sulfo hotspots in the chemokine receptor system
CRS2), which will trigger conformational changes that ultimately lead to receptor activation (Scholten D
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
#177 The Experiment That Was Never Meant to Succeed When David Hodson’s lab teamed up with chemist Johannes
- Decoding β-Arrestins: from Structure to function
of functional redundancy, as depleting one isoform results leads to relatively mild effects (Conner, D.
- Ode to GPCRs
Tilley, D. G. D. Regulation of nuclear factor κB activation by G-protein-coupled receptors.
- Structural landscape of the Chemokine Receptor system
to E2837.39 by A4 of CCL3; c) Route 3 - characterized by steric effects between TM2 and Y3 of CCL5; d)
- GPCR Buzz of the Week | Sep 23 - 29, 2024
🚀🎉 Kilian Roßmann , Joshua Levitz , Johannes Broichhagen for their excellent work on Deuteration
- 📰 GPCR Weekly News, February 19 to 25, 2024
This week's highlight includes congrats to: Johanna Lena Schön, and Dr.
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
Premium: Sneak Peek A curated preview of this week’s Premium classified content — designed to keep you ahead Stay ahead of competitors: Know when your data reflects equilibrium and when to probe deeper, ensuring Stay focused, informed, and ahead of your competitors while saving critical time each week. Dr. drug discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Don’t just keep pace, stay ahead. 40 years of expertise at your fingertips: Explore the complete library Stay ahead with The Kenakin Brief — a concise, science‑first email update with the latest insights in Always one step ahead.
- Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
This is your chance to get ahead of the curve.
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
busy scientists Influence the curriculum with your topic suggestions Weekly new releases to stay ahead , discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead Acting on the right signals today prevents tomorrow’s delays—and puts you ahead when budgets and timelines
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
For drug discovery teams and scientists, staying ahead requires more than just reading papers—it demands Stay ahead of the curve: Showcase your latest findings on the essential role GPCRs play in disease and drug discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
Get ahead, stay relevant, and lead—starting today. The Dr. GPCR Team Read Full Edition ➤
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
pharmacologists, biotech discovery teams, and decision-makers who need career-relevant intelligence to stay ahead Stay ahead. 🚀 Join Premium Today ➤
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Leverage this model to stay ahead of therapeutic complexity. drug discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead
- Understanding Enzyme Inhibition In GPCR Discovery Programs
curated, high-signal preview of what Premium Members get this week—no fluff, just the intel to keep you ahead biotech discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Hey GPCR Fans, This week's breakthroughs are crucial for staying ahead in the rapidly evolving landscape pharmacologists, biotech discovery teams, and decision-makers who need career-relevant intelligence to stay ahead
- 📰 GPCR Weekly News, March 4 to 10, 2024
Stay ahead of the curve! This week's highlight includes congrats to Drs. Please note that we moved our clocks ahead in North America.
- SLAS2022 International Conference and Exhibition
"We are moving ahead with SLAS2022 as an in-person event with a hybrid component.
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Premium: Sneak Peek A quick look at the curated intelligence our Premium members are using to stay ahead drug discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
where drug discovery is evolving faster than most can track, Terry’s Corner is your shortcut to staying ahead
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
pharmacologists, biotech discovery teams, and decision-makers who need career-relevant intelligence to stay ahead
- Why “Displacement” Misleads You: Allosteric Binding Demystified
Don’t just keep up, get ahead. 🟢 40 years of expertise at your fingertips: Explore the complete library
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Pharmacology Corner delivers trusted, razor-sharp insight to help drug discovery professionals like you stay ahead
- Do You Believe AI Could Accelerate Drug Discovery?
Looking ahead, AI offers significant advantages in drug development, such as the ability to tackle complex
- How Schild Analysis Protects Your Conclusions in GPCR Research
biotech discovery teams, and decision-makers who need concise, credible, high-value intelligence to stay ahead
- Innovative Data-Driven Solutions: The pHSense Revolution
. 🎧 Stay ahead.
- Curve Shifts Don’t Lie, But Your Eyes Might
Stay ahead. 🟢 40 years of expertise at your fingertips: Explore the complete library ➤ ✳️ Want to know
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
biotech discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead
